Unlisted
| Company Name | (주)안지오랩 |
| English Name | AngioLab, Inc. |
| Business Reg. No. | 3148126271 |
| CEO | 김민영 |
| Address | 대전광역시 유성구 테크노3로 65 |
| Industry | 기초 의약 물질 제조업 |
| Industry Code | 70113 |
| Main Products | 레몬밤추출물혼합분말, 황반변성치료제 ALS-L1023 |
| Established | 19990603 |
| Phone | 042-867-5785 |
| Website | www.angiolab.co.kr |
| Regular Employees | 16persons |
| Corp. Reg. No. | 1601110082795 |
Venture Certified
| 연구개발기업 | 1999-12-22 ~ 2001-12-21 | 1999152271-0362 | 1999-12-22 |
| 연구개발기업 | 2002-01-08 ~ 2004-01-07 | 021522021201284 | 1999-12-22 |
| 연구개발기업 | 2004-01-08 ~ 2006-01-07 | 031535021300298 | 1999-12-22 |
| 연구개발기업 | 2006-01-08 ~ 2008-01-07 | 61535021300039 | 1999-12-22 |
| 연구개발유형 | 2008-01-08 ~ 2010-01-07 | 20080100183 | 1999-12-22 |
| 연구개발유형 | 2010-01-08 ~ 2012-01-07 | 20100100835 | 1999-12-22 |
| 연구개발유형 | 2012-01-08 ~ 2014-01-07 | 20120100031 | 1999-12-22 |
| 기술평가보증기업(기금) | 2014-01-08 ~ 2016-01-07 | 20140100523 | 1999-12-22 |
| 연구개발유형 | 2016-01-08 ~ 2018-01-07 | 20150113341 | 1999-12-22 |
| 연구개발유형 | 2018-01-08 ~ 2020-01-07 | 20170114252 | 1999-12-22 |
| 연구개발유형 | 2020-01-08 ~ 2022-01-07 | 20190115013 | 1999-12-22 |
| 연구개발유형 | 2022-01-08 ~ 2025-01-07 | 20211223020012 | 1999-12-22 |
| 연구개발유형 | 2025-01-08 ~ 2028-01-07 | 20250102020028 | 1999-12-22 |
Revenue CAGR +42.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 20B | 5.0B | 10B |
| Operating Profit | -8.5B | -24B | -21B |
| Net Profit | -7.9B | -23B | -20B |
| Total Assets | 23B | 39B | 50B |
| Total Liabilities | 11B | 19B | 7.4B |
| Total Equity | 12B | 20B | 43B |
Operating Loss: Op. profit -8B
3 Consecutive Years of Net Loss
▲ 172.2%
▲ 62.5%
▲ 88.1%
▲ 57.1%
▲ 19.7%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 김민영 | 사내이사 | 경영총괄 | - |
| 박병영 | 사내이사 | 연구소 총괄 | - |
| 조명선 | 사외이사 | 연구자문 | - |
| 조일환 | 사내이사 | 전략개발총괄 | - |
| 서민석 | 미등기 | 경영지원 총괄 | - |
| 김인철 | 감사 | 내부감사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - |
| Regular Employees | 16persons |
| CEO | 김민영 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전광역시 유성구",
"ceo_name": "김민영",
"certificate": [
{
"cert_number": "1999152271-0362",
"changes": "",
"disclosure_date": "1999-12-22",
"first_cert_date": "1999-12-22",
"no": "1",
"type": "연구개발기업",
"valid_period": "1999-12-22 ~ 2001-12-21"
},
{
"cert_number": "021522021201284",
"changes": "",
"disclosure_date": "2002-01-08",
"first_cert_date": "1999-12-22",
"no": "2",
"type": "연구개발기업",
"valid_period": "2002-01-08 ~ 2004-01-07"
},
{
"cert_number": "031535021300298",
"changes": "",
"disclosure_date": "2004-01-08",
"first_cert_date": "1999-12-22",
"no": "3",
"type": "연구개발기업",
"valid_period": "2004-01-08 ~ 2006-01-07"
},
{
"cert_number": "61535021300039",
"changes": "",
"disclosure_date": "2006-01-08",
"first_cert_date": "1999-12-22",
"no": "4",
"type": "연구개발기업",
"valid_period": "2006-01-08 ~ 2008-01-07"
},
{
"cert_number": "20080100183",
"changes": "",
"disclosure_date": "2008-01-23",
"first_cert_date": "1999-12-22",
"no": "5",
"type": "연구개발유형",
"valid_period": "2008-01-08 ~ 2010-01-07"
},
{
"cert_number": "20100100835",
"changes": "",
"disclosure_date": "2010-02-10",
"first_cert_date": "1999-12-22",
"no": "6",
"type": "연구개발유형",
"valid_period": "2010-01-08 ~ 2012-01-07"
},
{
"cert_number": "20120100031",
"changes": "",
"disclosure_date": "2012-01-03",
"first_cert_date": "1999-12-22",
"no": "7",
"type": "연구개발유형",
"valid_period": "2012-01-08 ~ 2014-01-07"
},
{
"cert_number": "20140100523",
"changes": "",
"disclosure_date": "2014-01-20",
"first_cert_date": "1999-12-22",
"no": "8",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-01-08 ~ 2016-01-07"
},
{
"cert_number": "20150113341",
"changes": "",
"disclosure_date": "2015-12-04",
"first_cert_date": "1999-12-22",
"no": "9",
"type": "연구개발유형",
"valid_period": "2016-01-08 ~ 2018-01-07"
},
{
"cert_number": "20170114252",
"changes": "",
"disclosure_date": "2017-12-05",
"first_cert_date": "1999-12-22",
"no": "10",
"type": "연구개발유형",
"valid_period": "2018-01-08 ~ 2020-01-07"
},
{
"cert_number": "20190115013",
"changes": "",
"disclosure_date": "2019-12-19",
"first_cert_date": "1999-12-22",
"no": "11",
"type": "연구개발유형",
"valid_period": "2020-01-08 ~ 2022-01-07"
},
{
"cert_number": "20211223020012",
"changes": "",
"disclosure_date": "2021-12-23",
"first_cert_date": "1999-12-22",
"no": "12",
"type": "연구개발유형",
"valid_period": "2022-01-08 ~ 2025-01-07"
},
{
"cert_number": "20250102020028",
"changes": "",
"disclosure_date": "2025-01-02",
"first_cert_date": "1999-12-22",
"no": "13",
"type": "연구개발유형",
"valid_period": "2025-01-08 ~ 2028-01-07"
}
],
"company_name": "㈜안지오랩",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 2034309000,
"cost_of_sales": 183136000,
"current_assets": 4233023000,
"current_liabilities": 643877000,
"gross_profit": 822425000,
"net_income": -2011163000,
"net_income_bs": -2011163000,
"non_current_assets": 764007000,
"non_current_liabilities": 92166000,
"non_operating_expenses": 5785000,
"non_operating_income": 86810000,
"operating_profit": -2092188000,
"revenue": 1005561000,
"sga_expenses": 2914613000,
"total_assets": 4997030000,
"total_equity": 4260987000,
"total_liabilities": 736043000
},
"2023": {
"capital_stock": 2034308000,
"cost_of_sales": 395720000,
"current_assets": 3205956000,
"current_liabilities": 1842377000,
"gross_profit": 100926000,
"net_income": -2320700000,
"net_income_bs": -2320700000,
"non_current_assets": 712575000,
"non_current_liabilities": 107602000,
"non_operating_expenses": 4325000,
"non_operating_income": 117489000,
"operating_profit": -2433864000,
"revenue": 496646000,
"sga_expenses": 2534790000,
"total_assets": 3918531000,
"total_equity": 1968552000,
"total_liabilities": 1949979000
},
"2024": {
"capital_stock": 2034308000,
"cost_of_sales": 609991000,
"current_assets": 1728320000,
"current_liabilities": 998543000,
"gross_profit": 1434473000,
"net_income": -789733000,
"net_income_bs": -793962000,
"non_current_assets": 551342000,
"non_current_liabilities": 89798000,
"non_operating_expenses": 28291000,
"non_operating_income": 86194000,
"operating_profit": -847636000,
"revenue": 2044464000,
"sga_expenses": 2282109000,
"total_assets": 2279662000,
"total_equity": 1191321000,
"total_liabilities": 1088341000
}
},
"industry": "기초 의약 물질 제조업",
"investment": [],
"main_products": "레몬밤추출물혼합분말, 황반변성치료제 ALS-L1023",
"phone": "042-867-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 4/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |